Target intelligence / Profile preview

Gamma-aminobutyric acid type A receptor alpha4beta2delta (GABA_A receptor α4β2δ)

Target
GABA_A receptor α4β2δ
Molecular classification
Ionotropic GABA receptor, Ligand-gated ion channel, Cys-loop receptor family, Receptor
01

Overview

The Gamma-aminobutyric acid type A (GABA_A) receptor α4β2δ is a heteropentameric ligand-gated ion channel that serves as a primary mediator of tonic inhibition in the central nervous system. Unlike synaptic GABA_A receptors that facilitate rapid phasic inhibition, the α4β2δ subtype is predominantly located extrasynaptically in regions such as the thalamus, hippocampus, and cerebral cortex. These receptors are characterized by their high sensitivity to low concentrations of ambient GABA and their slow desensitization rates, which allow them to maintain a persistent inhibitory tone that regulates baseline neuronal excitability. The α4β2δ receptor is highly sensitive to modulation by neurosteroids, which act as potent positive allosteric modulators to enhance chloride conductance. Dysregulation of this receptor system is implicated in several neurological and psychiatric conditions, including catamenial epilepsy, postpartum depression, and anxiety disorders. Therapeutic agents like brexanolone and ganaxolone have been developed to target these receptors specifically, providing clinical benefits in treating mood and seizure disorders, although they are often associated with side effects such as sedation and motor incoordination.

Other names
Extrasynaptic GABA_A receptorα4β2δ GABA_A receptorDelta-containing GABA_A receptorGABAA receptor alpha4beta2delta
02

Mechanism of action

Positive allosteric modulation of the chloride channel to enhance tonic inhibitory currents; direct agonism at the GABA binding site.

03

Biological functions

Tonic inhibitionNeuronal excitability regulationChloride transportSynaptic plasticityNeurogenesis
04

Disease associations

EpilepsyPostpartum depressionAnxietyInsomniaAlcohol use disorderPremenstrual dysphoric disorderAutism spectrum disorder
05

Safety considerations

SedationAtaxiaRespiratory depressionPotential for abuse and dependenceWithdrawal symptoms
06

Interacting drugs

Brexanolone

6 more in the full profile.

07

Biomarkers

EEG beta/gamma oscillationsAllopregnanolone plasma levelsCerebrospinal fluid GABA levels

Beyond the preview

Go deeper on Gamma-aminobutyric acid type A receptor alpha4beta2delta (GABA_A receptor α4β2δ).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gamma-aminobutyric acid type A receptor alpha4beta2delta (GABA_A receptor α4β2δ).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call